MedPath
NMPA Approval

Tafluprost Eye Drops

国药准字H20244914

September 19, 2024

Drug Information

他氟前列素滴眼液

眼用制剂(滴眼剂)

0.0015%(0.3ml:4.5μg)

化学药品

September 19, 2024

Company Information

Applicant Company

陕西省咸阳市秦都区人民西路29号丽彩金方圆广场B座29层

Manufacturing Company

江苏省沭阳经济技术开发区宁波路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

他氟前列素滴眼液 - NMPA 批准文号 | MedPath